Skip to content
Screener

DexCom DXCM Q3 2025 earnings

Reported October 30, 2025 · After market close

Revenue$1.2BBeat by $25.6M
EPS$0.61Beat by $0.03
Revenue estimate$1.2B
EPS estimate$0.58

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$1.3B
EPS estimate$0.66

Financials

Q3 2025

Income statement

See full
Revenue$1.2B+21.6%
Gross profit$731.4M+23.2%
Operating income$242.5M+59.5%
Net income$283.8M+111%
EPS (diluted)$0.70+106%

Balance sheet

See full
Cash & equivalents$1.8B+195%
Total debt$128.8M-15.0%
Total equity$2.7B+37.8%
Total assets$7.5B+18.0%

Cash flow

See full
Operating cash flow$659.9M+231%
CapEx$80.5M-27.6%
Free cash flow$579.4M+556%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$26.39B-1.8%
Enterprise value$24.68B-6.5%
P/E36.6×-2.8×
P/S5.8×-1.0×

Profitability

See full
Gross margin59%-2.7pp
Operating margin17.2%+1.3pp
Net margin16%-1.3pp
FCF margin23.5%+10.0pp

Returns & leverage

See full
Return on equity30.6%-1.4pp
Debt / equity0×0.0×
Current ratio1.6×-0.9×

FAQ

When did DexCom report Q3 2025 earnings?
DexCom (DXCM) reported Q3 2025 earnings on October 30, 2025 after market close.
What were DexCom's Q3 2025 revenue and EPS?
DexCom reported revenue of $1.2B and eps of $0.61 for Q3 2025.
Did DexCom beat estimates in Q3 2025?
Revenue beat the consensus estimate of $1.2B by $25.6M. EPS beat the consensus estimate of $0.58 by $0.03.
How did DexCom's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.6% from $994.2M a year earlier and eps grew 35.6% from $0.45.
Where can I find DexCom's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001093557-25-000264) and the 10-Q periodic report (0001093557-25-000280) directly on SEC EDGAR. The filing index links above go to sec.gov.